BRPI0113372B8 - composição veterinária com veículo modificado e ceftiofur - Google Patents

composição veterinária com veículo modificado e ceftiofur

Info

Publication number
BRPI0113372B8
BRPI0113372B8 BRPI0113372A BRPI0113372A BRPI0113372B8 BR PI0113372 B8 BRPI0113372 B8 BR PI0113372B8 BR PI0113372 A BRPI0113372 A BR PI0113372A BR PI0113372 A BRPI0113372 A BR PI0113372A BR PI0113372 B8 BRPI0113372 B8 BR PI0113372B8
Authority
BR
Brazil
Prior art keywords
ceftiofur
composition
veterinary composition
modified vehicle
modified
Prior art date
Application number
BRPI0113372A
Other languages
English (en)
Inventor
Su Ching-Chiang
L Teagarden Dirk
M King Harry
F Caputo James
M Steele Jean
c eaton Leslie
L Whitmire Monica
J Britten Nancy
A Waldron Niki
Hendl Ondrej
Lee Schapaugh Randal
A Brown Scott
M Speaker Stanley
M Machkovech Susan
F Huda Syed
R Urban Terry
Original Assignee
Pah P&U Llc
Upjohn Co
Pharmacia & Upjohn Co Llc
Zoetis P&U Llc
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pah P&U Llc, Upjohn Co, Pharmacia & Upjohn Co Llc, Zoetis P&U Llc, Zoetis Services Llc filed Critical Pah P&U Llc
Publication of BR0113372A publication Critical patent/BR0113372A/pt
Publication of BRPI0113372B1 publication Critical patent/BRPI0113372B1/pt
Publication of BRPI0113372B8 publication Critical patent/BRPI0113372B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Abstract

"composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos". é propiciada uma composição caracterizada por compreender: (a) um ou mais agentes bioativos e (b) um carreador líquido modificado; em que, imediatamente a seguir à fabricação da composição, a referida composição pode ser administrada a um hospedeiro de modo que um ou mais dos agentes bioativos sejam liberados para o hospedeiro em uma base contínua.
BRPI0113372A 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur BRPI0113372B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23176700P 2000-09-12 2000-09-12
US60/231.767 2000-09-12
PCT/US2001/026013 WO2002022107A2 (en) 2000-09-12 2001-09-07 Pharmaceutical composition having modified carrier

Publications (3)

Publication Number Publication Date
BR0113372A BR0113372A (pt) 2003-06-24
BRPI0113372B1 BRPI0113372B1 (pt) 2017-08-01
BRPI0113372B8 true BRPI0113372B8 (pt) 2021-07-27

Family

ID=22870572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113372A BRPI0113372B8 (pt) 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur

Country Status (18)

Country Link
US (1) US20020110561A1 (pt)
EP (1) EP1317256B1 (pt)
JP (1) JP4738713B2 (pt)
AR (2) AR030648A1 (pt)
AT (1) ATE412405T1 (pt)
AU (2) AU8832301A (pt)
BR (1) BRPI0113372B8 (pt)
CA (1) CA2416566C (pt)
DE (1) DE60136367D1 (pt)
DK (1) DK1317256T3 (pt)
ES (1) ES2313981T3 (pt)
MX (1) MXPA03002055A (pt)
NZ (1) NZ524694A (pt)
PE (1) PE20030046A1 (pt)
PT (1) PT1317256E (pt)
TW (1) TWI284046B (pt)
WO (1) WO2002022107A2 (pt)
ZA (1) ZA200300617B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
CA2743551C (en) * 2008-11-19 2017-08-15 Merial Limited Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
BRPI0903778B1 (pt) 2009-07-17 2017-04-18 Cargill Agrícola S A composição alimentícia de gordura vegetal, processo de preparação de uma composição alimentícia de gordura vegetal e uso de uma composição alimentícia de gordura vegetal na preparação de recheio
WO2013049749A2 (en) * 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
CN107205440B (zh) 2014-11-19 2021-07-13 堪萨斯州立大学研究基金会 动物饲料和饲料成分中的化学缓和剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1055090C (zh) * 1993-03-12 2000-08-02 法玛西雅厄普约翰美国公司 结晶性头孢噻夫游离酸
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
NZ524694A (en) 2005-05-27
TWI284046B (en) 2007-07-21
US20020110561A1 (en) 2002-08-15
AU2001288323B2 (en) 2006-11-23
ATE412405T1 (de) 2008-11-15
PE20030046A1 (es) 2003-02-14
AR086688A2 (es) 2014-01-15
ES2313981T3 (es) 2009-03-16
CA2416566A1 (en) 2002-03-21
BRPI0113372B1 (pt) 2017-08-01
AU8832301A (en) 2002-03-26
JP4738713B2 (ja) 2011-08-03
EP1317256B1 (en) 2008-10-29
JP2004508395A (ja) 2004-03-18
DE60136367D1 (de) 2008-12-11
MXPA03002055A (es) 2004-12-13
AR030648A1 (es) 2003-08-27
PT1317256E (pt) 2008-12-17
DK1317256T3 (da) 2009-01-26
WO2002022107A3 (en) 2003-01-16
CA2416566C (en) 2011-05-31
WO2002022107A2 (en) 2002-03-21
BR0113372A (pt) 2003-06-24
ZA200300617B (en) 2004-04-22
EP1317256A2 (en) 2003-06-11

Similar Documents

Publication Publication Date Title
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BR0016012A (pt) Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
KR870005637A (ko) 약물 데포
BR0202375A (pt) Composições farmacêutica compreendendo drogas e polìmeros de aumento da concentração
BR9205640A (pt) Dímero de apolipoproteína ai-milano, composiçao farmacológica, processo de preparaçao do dímero, uso deste na preparaçao de medicamentos e processo para o tratamento de aterosclerose e doenças cardiovasculares
BRPI0110914B8 (pt) 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica'
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
BR9915818A (pt) Processo e composições para a prevenção de tolerância a medicações
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
BR0113710A (pt) Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
BR9807319A (pt) Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos.
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
BR9912218A (pt) Compostos obtidos de espécies de sálvia possuindo atividade antivirótica
BR9809571A (pt) Composição medicinal e processo para produzì-la
BRPI0113372B8 (pt) composição veterinária com veículo modificado e ceftiofur
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
BR9810703A (pt) Composição farmacêutica, e, processos para a preparação da mesma, e para tratar um distúrbio de agregação de plaqueta
BR0114272A (pt) Formulação farmacêutica de liberação prolongada independente da força iÈnica
BR0210744A (pt) Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: PHARMACIA AND UPJOHN COMPANY LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH PANDU LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS PANDU LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2001, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2430 DE 01/08/2017 - PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/08/2017, OBSERVADAS AS CONDICOES LEGAIS. JUSTIFICATIVA DE RETIFICACAO: PATENTE RELACIONADA A PRODUTO VETERINARIO.